Troponin I: an update on clinical utility and method standardization

Area of Science:

• Biochemistry
• Cardiology
• Clinical Diagnostics

Background:

• Cardiac troponin I (cTnI) is a critical biomarker for detecting myocardial injury.
• Its cardiac specificity has reshaped diagnostic criteria for various acute coronary syndromes and minor heart damage.
• Clinical application of cTnI has transformed the diagnosis and management of both acute and chronic heart conditions.

Purpose of the Study:

• To address the significant challenges in standardizing cardiac troponin I (cTnI) assays.
• To investigate the reasons behind the wide variations in cTnI measurements across different assay systems.
• To explore efforts toward biochemical standardization of cTnI assays.

Main Methods:

• Analysis of existing literature and data on cTnI assay performance.
• Examination of the biochemical properties of serum cTnI forms.
• Review of epitope recognition differences among various cTnI detection methods.

Main Results:

• Assays for cardiac troponin I (cTnI) exhibit up to 20-fold variability in measuring serum concentrations.
• This lack of standardization creates ambiguity in clinical interpretation of cTnI levels.
• Heterogeneity and complexity of serum cTnI, along with epitope recognition differences, impede assay harmonization.

Conclusions:

• Standardization of cardiac troponin I assays remains a significant challenge.
• The biochemical complexity of cTnI and assay-specific epitope recognition hinder harmonization efforts.
• Addressing these issues is crucial for reliable clinical interpretation and management of cardiac conditions.